Structural Genomics Consortium, Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt, Frankfurt am Main, Germany.
Structural Genomics Consortium, University of Toronto, Toronto, Canada.
Elife. 2018 Apr 20;7:e34311. doi: 10.7554/eLife.34311.
Potent, selective and broadly characterized small molecule modulators of protein function (chemical probes) are powerful research reagents. The pharmaceutical industry has generated many high-quality chemical probes and several of these have been made available to academia. However, probe-associated data and control compounds, such as inactive structurally related molecules and their associated data, are generally not accessible. The lack of data and guidance makes it difficult for researchers to decide which chemical tools to choose. Several pharmaceutical companies (AbbVie, Bayer, Boehringer Ingelheim, Janssen, MSD, Pfizer, and Takeda) have therefore entered into a pre-competitive collaboration to make available a large number of innovative high-quality probes, including all probe-associated data, control compounds and recommendations on use (
强效、选择性和广泛表征的蛋白质功能小分子调节剂(化学探针)是强大的研究试剂。制药行业已经生成了许多高质量的化学探针,其中一些已经提供给学术界。然而,探针相关的数据和对照化合物,如无活性的结构相关分子及其相关数据,通常无法获得。缺乏数据和指导使得研究人员难以决定选择哪种化学工具。因此,几家制药公司(艾伯维、拜耳、勃林格殷格翰、杨森、默沙东、辉瑞和武田)已经达成了一项非竞争性合作,提供大量创新的高质量探针,包括所有探针相关数据、对照化合物以及使用建议(